New Chapter in Greater Bay Area Development: Hengqin Guangdong-Macao In-depth Cooperation Zone Implements VAT and Consumption Tax Refund Policies
The Hengqin Guangdong-Macao In-depth Cooperation Zone introduces VAT and consumption tax refund policies effective from March 1, 2024, to boost economic integration and development, marking a strategic effort to enhance business and trade attractiveness by treating certain imported goods as exports and facilitating tax refunds for qualifying businesses, thus fostering greater economic synergy between Guangdong province and Macao.
Read MoreChina Sets New Benchmarks in Medical Device Industry with Ambitious 2023 Standardization Initiatives
In 2023, China significantly advanced its medical device industry by approving and publishing a wide range of national and industry standards, establishing key standardization technical organizations, and reinforcing its commitment to safety, innovation, and global competitiveness.
Read MoreGuidelines for the Performance Evaluation of Pathological Image AI Analysis Software: Ensuring Accuracy and Compliance in Medical Diagnostics
The "Key Points for the Performance Evaluation Review of Pathological Image AI Analysis Software" provides essential guidelines for the evaluation of AI software in pathology, covering data collection, algorithm performance, and safety standards to ensure the reliability and effectiveness of AI diagnostics tools.
Read MoreChina Announces the Release of 20 New Medical Device Industry Standards
On February 19, 2024, the National Medical Products Administration (NMPA) of China announced the release and implementation of 20 revised and new standards for medical devices, aimed at enhancing product quality, safety, and regulatory compliance across a broad spectrum of medical technologies.
Read MoreNew Measures to Support the Development of the Modern Life Sciences and Biotechnology Industry in Xiong'an New Area
Xiong'an New Area introduces comprehensive measures to support the life sciences and biotechnology sectors, including financial incentives for the industrialization of medical devices, support for international registration and certification of drugs and devices, subsidies for public service platform establishment, encouragement of special medical food industry development, and promotion of pharmaceutical clinical application and research, aiming to foster innovation and position the area as a leading hub in these fields.
Read MoreChina Enhances Medical Device Registration and Supervision in 2023
In 2023, China significantly advanced its medical device regulatory framework, innovation approval rates, and international standardization efforts, while also enhancing clinical trial, registration, and standard quality management.
Read MoreBreakthrough in Obesity Treatment: Gastric Bypass Stent System NMPA Review Unveiled
A landmark clinical trial for an innovative medical device has shown significant weight loss in subjects, underscoring a commitment to advancing non-surgical obesity treatments and medical technology innovation.
Read MoreEmbracing Single-Arm Study Design in the Wake of NMPA's Clinical Evaluation Reforms for Medical Device Innovation
The NMPA CMDE are advancing medical device innovation with reforms focusing on single-arm study designs to enhance clinical evaluations, ensuring devices meet the highest standards of safety and efficacy for end-users.
Read MoreAddressing the Complexities of Single-Arm Clinical Trials in Medical Device Innovation
TX Medical News emphasizes the critical need for careful, evidence-based selection of single-arm clinical trial designs in medical device innovation, ensuring safety and efficacy while addressing the unique challenges of groundbreaking technologies.
Read MoreHangzhou Tangji Medical Technology Pioneers with NMPA-Approved Gastric Bypass Stent System
The NMPA's approval of Hangzhou Tangji Medical Technology's innovative Gastric Bypass Stent System introduces a non-surgical obesity management solution, promising a safer alternative for effective weight loss.
Read More